Register | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

worx11's depression [24 articles]

Recent papers added to worx11's library classified by the tag depression. You can also see everyone's depression.
  • Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
    Int Clin Psychopharmacol, Vol. 22, No. 2. (March 2007), pp. 107-115.
    by B Fantino, N Moore, H Verdoux, JP Auray
    posted to as depression by worx11 on 2007-10-18 17:22:13 as ** along with 1 group XROWXR
  • SSRIs versus other antidepressants for depressive disorder.
    Cochrane Database Syst Rev, No. 2. (2000)
    by JR Geddes, N Freemantle, J Mason, MP Eccles, J Boynton
    posted to as depression by worx11 on 2007-10-18 13:30:13 as ** along with 1 group XROWXR
  • WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Cochrane Database Syst Rev, No. 3. (2007)
    by C Barbui, M Hotopf, N Freemantle, J Boynton, R Churchill, MP Eccles, JR Geddes, R Hardy, G Lewis, JM Mason
    posted to as depression by worx11 on 2007-10-18 13:29:50 as ** along with 1 group XROWXR
  • WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
    Cochrane Database Syst Rev, No. 3. (2007)
    by JR Geddes, N Freemantle, J Mason, MP Eccles, J Boynton
    posted to as depression by worx11 on 2007-10-18 13:29:29 as ** along with 1 group XROWXR
  • [Review of double-blind studies comparing SSRI and SNRI]
    Seishin Shinkeigaku Zasshi, Vol. 106, No. 10. (2004), pp. 1203-1217.
    by E Suzuki, S Maruta
    posted to as depression by worx11 on 2007-10-18 13:29:01 as ** along with 1 group XROWXR
  • An overview of SSRI and SNRI therapies for depression.
    Manag Care, Vol. 13, No. 6 Suppl Depression. (June 2004), pp. 25-33.
    by JB Weilburg
    posted to as depression by worx11 on 2007-10-18 13:28:33 as ** along with 1 group XROWXR
  • Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.
    J Clin Psychiatry, Vol. 67, No. 12. (December 2006), pp. 1836-1855.
    by HG Ruhé, J Huyser, JA Swinkels, AH Schene
  • Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder
    Current Medical Research and Opinion, Vol. 23, No. 2. (February 2007), pp. 251-258.
    by Armstrong, P Edward, Skrepnek, H Grant, Haim Erder,
    posted to as depression by worx11 on 2007-08-22 17:50:54 as ** along with 1 group XROWXR
  • Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan
    Journal of Clinical Pharmacy & Therapeutics, Vol. 32, No. 4. (August 2007), pp. 353-363.
    by Wu, -S, Chen, -C, Lu, -B
    posted to as depression by worx11 on 2007-08-22 17:45:43 as ** along with 1 group XROWXR
  • Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women.
    Arch Gen Psychiatry, Vol. 62, No. 8. (August 2005), pp. 868-875.
    by DA Revicki, J Siddique, L Frank, JY Chung, BL Green, J Krupnick, M Prasad, J Miranda
    posted to as depression by worx11 on 2007-08-22 17:12:39 as ** along with 1 group XROWXR
  • Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.
    Pharmacoeconomics, Vol. 23, No. 2. (2005), pp. 155-167.
    posted to as depression by worx11 on 2007-08-22 17:12:14 as ** along with 1 group XROWXR
  • Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany.
    Eur J Health Econ, Vol. 6, No. 4. (December 2005), pp. 317-321.
    posted to as depression by worx11 on 2007-08-22 17:08:41 as ** along with 1 group XROWXR
  • A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium
    Clinical Therapeutics, Vol. 27, No. 1. (January 2005), pp. 111-124.
    by Koen Demyttenaere, Michiel E Hemels, Joumana Hudry, Lieven Annemans
    posted to as depression by worx11 on 2007-08-22 17:05:44 as ** along with 1 group XROWXR
  • A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom
    Clinical Therapeutics, Vol. 27, No. 4. (April 2005), pp. 486-496.
    by Alan G Wade, Idris Toumi, Michiel E Hemels
    posted to as depression by worx11 on 2007-08-22 16:54:52 as ** along with 1 group XROWXR
  • A budget-impact and cost-effectiveness model for second-line treatment of major depression.
    J Manag Care Pharm, Vol. 13, No. 6. (g 2007), pp. 8-18.
    by DC Malone
    posted to as depression by worx11 on 2007-08-22 16:07:51 as ** along with 1 group XROWXR
  • Evidence of cost-effective treatments for depression: a systematic review.
    J Affect Disord, Vol. 84, No. 1. (January 2005), pp. 1-13.
    by B Barrett, S Byford, M Knapp
    posted to as depression by worx11 on 2007-08-22 16:07:06 as ** along with 1 group XROWXR
  • Discontinuation symptoms in depression and anxiety disorders.
    Int J Neuropsychopharmacol (19 December 2005), pp. 1-12.
    by David S S Baldwin, Stuart A A Montgomery, Rico Nil, Malcolm Lader
    posted to as depression by worx11 on 2007-08-21 20:25:18 as ** along with 1 person and 1 group torfis XROWXR
  • Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents.
    Biol Psychiatry (21 June 2007)
    by George I I Papakostas, Michael E E Thase, Maurizio Fava, J Craig Nelson, Richard C C Shelton
    posted to as depression by worx11 on 2007-08-21 20:20:58 as ** along with 1 group XROWXR
  • Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation
    International Journal of Clinical Practice, Vol. 61, No. 4. (April 2007), pp. 702-710.
    posted to as depression by worx11 on 2007-08-21 20:04:59 as ** along with 1 group XROWXR
  • Evidence based review of escitalopram in treating major depressive disorder in primary care.
    Int Clin Psychopharmacol, Vol. 19, No. 5. (September 2004), pp. 305-310.
    by TR Einarson
    posted to as depression by worx11 on 2007-08-21 20:00:43 as ** along with 1 group XROWXR
  • Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.
    Ann Intern Med, Vol. 143, No. 6. (20 September 2005), pp. 415-426.
    by RA Hansen, G Gartlehner, KN Lohr, BN Gaynes, TS Carey
    posted to ahrq as depression by worx11 on 2007-08-21 19:56:20 as ** along with 1 group XROWXR
  • Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder
    Current Medical Research and Opinion, Vol. 23, No. 6. (June 2007), pp. 1303-1318.
    posted to ahrq as depression by worx11 on 2007-08-21 19:49:16 as ** along with 1 group XROWXR
  • A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder
    Current Medical Research and Opinion, Vol. 23, No. 7. (July 2007), pp. 1605-1614.
    by Wade, , Gembert, , Florea,
    posted to ahrq as depression by worx11 on 2007-08-21 19:44:13 as ** along with 1 group XROWXR
  • Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Clin Drug Investig, Vol. 27, No. 7. (2007), pp. 481-492.
    by A Khan, A Bose, GS Alexopoulos, C Gommoll, D Li, C Gandhi
    posted to ahrq as depression by worx11 on 2007-08-21 19:37:12 as ** along with 1 group XROWXR
  • Note: You may cite this page as: http://www.citeulike.org/user/worx11/tag/depression

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.